Research ArticleOncology
Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt and Wolfgang A. Weber
Journal of Nuclear Medicine September 2021, 62 (9) 1228-1234; DOI: https://doi.org/10.2967/jnumed.120.258384
Stephanie Robu
1Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany;
Antonia Richter
1Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany;
Dario Gosmann
2School of Medicine, Clinic and Policlinic for Internal Medicine III, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany;
Christof Seidl
1Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany;
David Leung
3Bristol-Myers Squibb Research and Development, Princeton, New Jersey;
Wendy Hayes
3Bristol-Myers Squibb Research and Development, Princeton, New Jersey;
Daniel Cohen
3Bristol-Myers Squibb Research and Development, Princeton, New Jersey;
Paul Morin
3Bristol-Myers Squibb Research and Development, Princeton, New Jersey;
David J. Donnelly
3Bristol-Myers Squibb Research and Development, Princeton, New Jersey;
Daša Lipovšek
3Bristol-Myers Squibb Research and Development, Princeton, New Jersey;
Samuel J. Bonacorsi
3Bristol-Myers Squibb Research and Development, Princeton, New Jersey;
Adam Smith
3Bristol-Myers Squibb Research and Development, Princeton, New Jersey;
Katja Steiger
4Institute of Pathology, School of Medicine, Technical University of Munich, Munich, Germany;
5German Cancer Consortium, Munich, Germany, and German Cancer Research Center, Heidelberg, Germany; and
Christina Aulehner
2School of Medicine, Clinic and Policlinic for Internal Medicine III, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany;
Angela M. Krackhardt
2School of Medicine, Clinic and Policlinic for Internal Medicine III, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany;
5German Cancer Consortium, Munich, Germany, and German Cancer Research Center, Heidelberg, Germany; and
Wolfgang A. Weber
1Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany;
5German Cancer Consortium, Munich, Germany, and German Cancer Research Center, Heidelberg, Germany; and
6TranslaTUM (Zentralinstitut für translationale Krebsforschung der Technischen Universität München), Munich, Germany

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 9
September 1, 2021
Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt, Wolfgang A. Weber
Journal of Nuclear Medicine Sep 2021, 62 (9) 1228-1234; DOI: 10.2967/jnumed.120.258384
Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt, Wolfgang A. Weber
Journal of Nuclear Medicine Sep 2021, 62 (9) 1228-1234; DOI: 10.2967/jnumed.120.258384
Jump to section
Related Articles
Cited By...
- No citing articles found.